BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 10600405)

  • 1. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
    Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
    Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
    Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
    J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Utrophin, a way to cure Duchenne muscle dystrophy].
    Gillis JM
    Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.
    Rafael JA; Brown SC
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscular nitric oxide synthase (muNOS) and utrophin.
    Chaubourt E; Voisin V; Fossier P; Baux G; Israël M; De La Porte S
    J Physiol Paris; 2002; 96(1-2):43-52. PubMed ID: 11755782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-arginine improves dystrophic phenotype in mdx mice.
    Voisin V; Sébrié C; Matecki S; Yu H; Gillet B; Ramonatxo M; Israël M; De la Porte S
    Neurobiol Dis; 2005 Oct; 20(1):123-30. PubMed ID: 16137573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
    Miura P; Jasmin BJ
    Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NO way to increase muscular utrophin expression?
    Chaubourt E; Voisin V; Fossier P; Baux G; Israël M; de La Porte S
    C R Acad Sci III; 2000 Aug; 323(8):735-40. PubMed ID: 11019368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy.
    Ségalat L; Grisoni K; Archer J; Vargas C; Bertrand A; Anderson JE
    Exp Cell Res; 2005 Jan; 302(2):170-9. PubMed ID: 15561099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse.
    Gramolini AO; Wu J; Jasmin BJ
    Microsc Res Tech; 2000 Apr; 49(1):90-100. PubMed ID: 10757882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
    Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
    Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
    Gillis JM
    Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
    Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
    Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
    Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
    FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle.
    Matsumura K; Ervasti JM; Ohlendieck K; Kahl SD; Campbell KP
    Nature; 1992 Dec; 360(6404):588-91. PubMed ID: 1461282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
    Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
    Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
    Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE
    Nature; 1996 Nov; 384(6607):349-53. PubMed ID: 8934518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex.
    Judge LM; Haraguchiln M; Chamberlain JS
    J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.